Adage Capital Management, L.p. - Net Worth and Insider Trading
Adage Capital Management, L.p. Net Worth
The estimated net worth of Adage Capital Management, L.p. is at least $16 Million dollars as of 2025-06-05. Adage Capital Management, L.p. is the 10% Owner of Solid Biosciences Inc and owns about 4,248,084 shares of Solid Biosciences Inc (SLDB) stock worth over $16 Million. Details can be seen in Adage Capital Management, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Adage Capital Management, L.p. has not made any transactions after 2025-02-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Adage Capital Management, L.p.
Adage Capital Management, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Adage Capital Management, L.p. owns 1 companies in total, including Abeona Therapeutics Inc (ABEO) .
Click here to see the complete history of Adage Capital Management, L.p.’s form 4 insider trades.
Insider Ownership Summary of Adage Capital Management, L.p.
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ABEO | Abeona Therapeutics Inc | 2023-07-03 | 10 percent owner |
Adage Capital Management, L.p. Latest Holdings Summary
Adage Capital Management, L.p. currently owns a total of 1 stock. Adage Capital Management, L.p. owns 4,248,084 shares of Solid Biosciences Inc (SLDB) as of February 18, 2025, with a value of $16 Million.
Latest Holdings of Adage Capital Management, L.p.
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SLDB | Solid Biosciences Inc | 2025-02-18 | 4,248,084 | 3.84 | 16,312,643 |
Holding Weightings of Adage Capital Management, L.p.
Adage Capital Management, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Adage Capital Management, L.p. has made a total of 1 transactions in Solid Biosciences Inc (SLDB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Solid Biosciences Inc is the acquisition of 252,545 shares on February 18, 2025, which cost Adage Capital Management, L.p. around $2 Million.
Insider Trading History of Adage Capital Management, L.p.
- 1
Adage Capital Management, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Adage Capital Management, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Adage Capital Management, L.p. is -47.74%. GuruFocus also compares Adage Capital Management, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Adage Capital Management, L.p. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Adage Capital Management, L.p.'s insider trading performs compared to the benchmark.
Performance of Adage Capital Management, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -6.98 |  | | | | |
| Relative Return to S&P 500(%) | 1.42 | | | | | |
Adage Capital Management, L.p. Ownership Network
Ownership Network List of Adage Capital Management, L.p.
Ownership Network Relation of Adage Capital Management, L.p.
Adage Capital Management, L.p. Owned Company Details
What does Abeona Therapeutics Inc do?
Who are the key executives at Abeona Therapeutics Inc?
Adage Capital Management, L.p. is the 10 percent owner of Abeona Therapeutics Inc. Other key executives at Abeona Therapeutics Inc include director & Chief Executive Officer Vishwas Seshadri , Chief Financial Officer Christine Berni Silverstein , and SVP & General Counsel Brendan M. O'malley .
Abeona Therapeutics Inc (ABEO) Insider Trades Summary
Over the past 18 months, Adage Capital Management, L.p. made no insider transaction in Abeona Therapeutics Inc (ABEO). Other recent insider transactions involving Abeona Therapeutics Inc (ABEO) include a net sale of 50,974 shares made by Mark Alvino , a net purchase of 5,000 shares made by Vishwas Seshadri , and a net sale of 25,821 shares made by Christine Berni Silverstein .
In summary, during the past 3 months, insiders sold 35,000 shares of Abeona Therapeutics Inc (ABEO) in total and bought 0 shares, with a net sale of 35,000 shares. During the past 18 months, 101,795 shares of Abeona Therapeutics Inc (ABEO) were sold and 62,758 shares were bought by its insiders, resulting in a net sale of 39,037 shares.
Abeona Therapeutics Inc (ABEO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Abeona Therapeutics Inc Insider Transactions
Adage Capital Management, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Adage Capital Management, L.p.. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Adage Capital Management, L.p.'s mailing address is: Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
